Skip to main content
ENOV
NYSE Industrial Applications And Services

Enovis 10-Q: Q3 Net Income $3.4M, $170.5M Nine-Month Operating Cash Flow, No Goodwill Impairment

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Industrial Machinery Stocks · Industrial
Sentiment info
Neutral
Importance info
7
Price
$25.77
Mkt Cap
$1.408B
52W Low
$16.7
52W High
$32.41
52W Position info
54% above low
Off High info
20% below high
Rel. Volume info
2.4× avg
Market data snapshot near publication time

ENOV sits 54% above its 52-week low of $16.7 on elevated volume (2.4× avg).

Summary

Enovis' Q3 10-Q shows a $3.4 million GAAP profit (versus a $570.9 million loss a year ago, which carried a $548.4 million goodwill write-down), $170.5 million of nine-month operating cash flow, and no goodwill impairment after an interim test — but cash is down to $13.0 million and a federal False Claims Act probe now names the Company as a potential subject.


Key Events · Earnings and Guidance · ENOV

  • Q3 GAAP Profit on Flat Operating Income

    Net sales of $558.7 million rose 1.8% reported and 4.6% organic; GAAP net income was $3.4 million ($0.06 per diluted share) versus a $570.9 million loss a year ago, a swing driven by the absence of last year's $548.4 million goodwill impairment rather than operating leverage — operating income was $3.4 million.

  • Cash Flow Strong, Cash Balance Thin

    Nine-month operating cash flow was $170.5 million, up $41.8 million year-over-year, funding $133.2 million of capital spending and $43.3 million of net debt repayment; cash and equivalents still fell to $13.0 million from $36.4 million at December 31, 2025.

  • No Goodwill Impairment After Interim Test

    Following a decline in share price and market capitalization, Enovis ran a quantitative goodwill test as of October 2, 2026 and recorded no impairment; management states the combined fair value of its two reporting units implies roughly a 46% premium to current market capitalization, leaving limited headroom if the stock falls further.

  • Liquidity and Covenants Intact

    Total debt was $1.26 billion against $958 million available on the $1.1 billion revolver, and the Company was in compliance with its 3.50:1.00 senior secured leverage and 3.00:1.00 interest coverage covenants.


Analysis · ENOV · Industrial Applications And Services

The 10-Q fills in what the morning's 8-K only summarized. The quarter flipped to a $3.4 million GAAP profit from a $570.9 million loss a year ago, but that swing is almost entirely the absence of last year's $548.4 million goodwill write-down, not an operating turnaround — operating income was just $3.4 million on $558.7 million of sales. Cash tells the more useful story: nine-month operating cash flow of $170.5 million funded $133.2 million of capital spending and $43.3 million of net debt repayment, yet cash still fell to $13.0 million from $36.4 million. With $958 million undrawn on the revolver and covenant compliance affirmed, liquidity is not the issue — but a $13 million cash balance leaves little cushion. Management also ran an interim goodwill test after the share price fell and booked no impairment, saying the sum of its two reporting units' fair values implies roughly a 46% premium to the current market capitalization; that is a thin margin of safety if the stock weakens further. Separately, the legal footnote discloses that the latest U.S. Attorney CID now names the Company itself among potential subjects of a False Claims Act investigation, alongside a former distributor, a hospital and surgeons — scope and outcome cannot be predicted.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ENOV was trading at $25.77 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $1.4B. The 52-week trading range was $16.70 to $32.41. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ENOV - Latest Insights

ENOV
Nov 05, 2026, 12:05 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $27.64
Real-time Price: $26.23 info
Change: -$1.41 (-5%) info
Market Cap: $1.513B info
ENOV
Nov 05, 2026, 6:10 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $25.77
Real-time Price: $26.23 info
Change: +$0.460 (+2%) info
Market Cap: $1.513B info
ENOV
Nov 05, 2026, 6:00 AM EST
Source: Wiseek News
Importance Score:
8
Price at Filing: $24.35
Real-time Price: $26.23 info
Change: +$1.88 (+8%) info
Market Cap: $1.513B info
ENOV
Sep 01, 2026, 6:30 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $24.59
Real-time Price: $26.23 info
Change: +$1.64 (+7%) info
Market Cap: $1.513B info
ENOV
Sep 01, 2026, 6:30 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $24.59
Real-time Price: $26.23 info
Change: +$1.64 (+7%) info
Market Cap: $1.513B info